← Leaderboards
Kevin J French
Apogee Biotechnology Corporation
$673,119
Attributed
$673,119
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$673,119 · 3
By mechanism
R43$673,119 · 3
Top collaborators
No co-investigators on record.
Most similar at Apogee Biotechnology Corporation
Same institution · by research overlap
- Charles D Smith$4,163,780
- Zuping Xia$491,543
- Yan Zhuang$492,349
- Leo Robert Fitzpatrick$996,642
- Lynn Maines$219,476
Others in their field
Top investigators on “Pharmacokinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$237,100,725
- Constance Ann Benson · University Of California, San Diego$151,891,628
- Richard L Schilsky · University Of Chicago$114,474,127
- Ronald T Mitsuyasu · University Of California Los Angeles$105,970,100
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,574,471
- Myron S Cohen · Family Health International$91,263,426
Research focus
PharmacokineticsMass SpectrometryDrug Screening /EvaluationAlcohol PhosphotransferaseDrug Design /Synthesis /ProductionDrug Discovery /IsolationScid MouseSphingosineTerminal Nick End LabelingEnzyme InhibitorsFlow CytometryCombinatorial ChemistryCell LineCytotoxicityLaboratory MouseAntineoplasticsNuclear Magnetic Resonance SpectroscopyTumor Necrosis Factor AlphaAntiaids AgentAntiviral AgentsCombination ChemotherapyDisease /Disorder ModelDrug Adverse EffectHigh Performance Liquid Chromatography